Participants 42 108 4
risk of stroke and bleeding events in atrial fibrillation patients
Participants 488 592 6
ACTIVE W study patients, cases with stroke and cases with bleeding were separately matched with controls
Participants 698 939 6
32 cases with ischemic stroke and 234 cases with bleeding in the analysis were matched in a 4:1 ratio to 122 and 865 controls, respectively. Follow-up duration was 257±154days for the stroke analysis and 222±146days for the bleeding analys
Participants 1441 1487 3
ower in individual AF patients with stroke or 
